|
|||||
|
|
Prolactin Promotes Hepatocellular Carcinoma through Janus Kinase 2 |
|
| Authors: | Yao-Tsung?Yeh,King-Teh?Lee,Chia-Jung?Tsai,Yu-Jie?Chen,Shen-Nien?Wang mailto:snwang@kmu.edu.tw" title=" snwang@kmu.edu.tw" itemprop=" email" data-track=" click" data-track-action=" Email author" data-track-label=" " >Email author |
| Affiliation: | (1) Department of Medical Laboratory Sciences and Biotechnology, Fooyin University, Kaohsiung, Taiwan;(2) Department of Surgery, Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan;(3) Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan;(4) Cancer Center, Kaohsiung Medical University Hospital, No. 100, Tzyou 1st Rd., Kaohsiung, Taiwan; |
| Abstract: | BackgroundHepatocelluar carcinoma (HCC) is one human cancer with obvious gender disparity. This study investigated the association of aberrant prolactin levels with HCC risk and the potential impacts on HCC of the prolactin receptor (PRLR)/Janus kinase 2 (JAK2) signaling. |
| Keywords: | |
| 本文献已被 PubMed SpringerLink 等数据库收录！ | |